PREDICTMEDIX AI INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 CAD | +20.00% |
|
0.00% | -33.33% |
| Sales 2022 | 0.13 0.18 | Sales 2023 | 0.04 0.05 | Capitalization | 8.54M 11.68M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -1.37M | Net income 2023 | -2M -2.73M | EV / Sales 2022 | 95,496,610 x |
| Net cash position 2022 | 211K 289K | Net cash position 2023 | 41.38K 56.56K | EV / Sales 2023 | 242,781,553 x |
| P/E ratio 2022 |
-6.88
x | P/E ratio 2023 |
-3.87
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.46% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +20.00% | ||
| Current month | -25.00% | ||
| 1 month | -25.00% | ||
| 3 months | -50.00% | ||
| 6 months | -50.00% | ||
| Current year | -33.33% |
1 week
0.03
0.03
1 month
0.030.04
Current year
0.030.09
1 year
0.030.16
3 years
0.030.54
5 years
0.001.15
10 years
0.001.15
| Managers | Title | Age | Since |
|---|---|---|---|
Sheldon Kales
CEO | Chief Executive Officer | 67 | 19-09-22 |
Rakesh Malhotra
DFI | Director of Finance/CFO | 67 | 19-09-22 |
Rajiv Muradia
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sheldon Kales
CEO | Chief Executive Officer | 67 | 19-09-22 |
Tomas Sipos
BRD | Director/Board Member | 62 | 19-09-22 |
Rahul Kushwah
COO | Chief Operating Officer | 40 | 18-12-11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 0.03 | +20.00% | 103,000 |
| 24-04-23 | 0.025 | -16.67% | 402,000 |
| 24-04-22 | 0.03 | 0.00% | 344,371 |
| 24-04-19 | 0.03 | -14.29% | 31,330 |
Delayed Quote Canadian Securities Exchange, April 24, 2024 at 02:30 pm EDT
More quotes
Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Companyâs Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Companyâs autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.
Calendar
2024-05-28
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -33.33% | 3.29M | |
| +6.56% | 32.91B | |
| +17.38% | 8.1B | |
| -2.71% | 6.98B | |
| +20.18% | 5.45B | |
| -3.97% | 4.13B | |
| +34.04% | 3.95B | |
| +5.47% | 3.4B | |
| -9.99% | 2.72B | |
| +8.20% | 2.43B |
- Stock Market
- Equities
- PMED Stock
